Boston Scientific Execs to Field Analyst Questions at TD Cowen Conference
Event summary
- Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference on March 3, 2026.
- CEO Mike Mahoney and Chief Medical Officer Kenneth Stein, M.D., will lead a 30-minute Q&A session at 9:10 a.m. ET.
- Live webcast and replay available on Boston Scientific's investor relations page.
- Event follows Boston Scientific's 45-year history as a global medical technology leader.
The big picture
Boston Scientific's participation in TD Cowen's conference comes amid heightened scrutiny on medical device companies to balance innovation with cost containment. The session offers a platform to address investor concerns about its ability to maintain growth in a competitive landscape. The company's focus on reducing healthcare costs aligns with broader industry trends toward value-based care.
What we're watching
- Strategic Messaging
- How Boston Scientific frames its innovation pipeline and cost-reduction efforts during the Q&A.
- Market Sentiment
- Whether the session shifts investor perception of Boston Scientific's competitive positioning.
- Execution Risk
- The pace at which Boston Scientific can deliver on unmet patient needs across its broad portfolio.
Related topics